BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 5288260)

  • 1. Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro.
    Ho MW; O'Brien JS
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2810-3. PubMed ID: 5288260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen.
    Butterworth J; Broadhead DM
    Clin Chim Acta; 1978 Aug; 87(3):433-40. PubMed ID: 28186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
    Garrett KO; Prence EM; Glew RH
    Arch Biochem Biophys; 1985 Apr; 238(1):344-52. PubMed ID: 3920967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identity of 'acid' beta-glucosidase and glucocerebrosidase in human spleen.
    Ho MW
    Biochem J; 1973 Nov; 136(3):721-9. PubMed ID: 4780697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoenzymes of membrane-bound beta-glucosidase of human spleen.
    Yaqoob M; Carroll M
    Biochem J; 1980 Feb; 185(2):541-3. PubMed ID: 6772153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M; Sakiyama T; Kitagawa T
    Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
    Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple forms of acid phosphatase activity in Gaucher's disease.
    Chambers JP; Peters SP; Glew RH; Lee RE; McCafferty LR; Mercer DW; Wenger DA
    Metabolism; 1978 Jul; 27(7):801-14. PubMed ID: 26832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
    Choy FY; Davidson RG
    Pediatr Res; 1980 Jan; 14(1):54-9. PubMed ID: 6767218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.
    Carroll M
    J Inherit Metab Dis; 1985; 8(1):33-7. PubMed ID: 3921758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte glucocerebrosidase deficiency diagnostic in adult Gaucher's disease with negative bone marrow biopsy. Some properties of the enzyme in leukocytes and spleen.
    Klibansky C; Hoffmann J; Pinkhas J; Algom D; Dintzman M; Ben-Bassat M; De Vries A
    Eur J Clin Invest; 1974 Apr; 4(2):101-7. PubMed ID: 4832717
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH; Daniels LB; Clark LS; Hoyer SW
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple forms of membrane-bound beta-glucosidase in Gaucher's disease.
    Yaqoob M; Carroll M
    Clin Genet; 1981 Aug; 20(2):161-7. PubMed ID: 6796311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-glucosidase activities in human tissues. Findings in Gaucher's disease.
    Hultberg B; Ockerman PA
    Clin Chim Acta; 1970 Apr; 28(1):169-74. PubMed ID: 5440282
    [No Abstract]   [Full Text] [Related]  

  • 15. [Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease].
    Maret A; Salvayre R; Nègre A; Douste-Blazy L
    Biomedicine; 1980 May; 33(3):82-6. PubMed ID: 6778520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)].
    Maret A; Salvayre R; Negre A; Douste-Blazy L
    Eur J Biochem; 1981 Apr; 115(3):455-61. PubMed ID: 6786882
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta-glucosidases. Molecular bases of Gaucher's disease].
    Maret A; Salvayre R; Negre A; Douste-Blazy L
    Pathol Biol (Paris); 1985 Jun; 33(6):693-713. PubMed ID: 3931039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical and kinetic properties of beta-glucosidase in Gaucher disease.
    Karazeh A; Carroll M
    J Inherit Metab Dis; 1983; 6(3):101-4. PubMed ID: 6422137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro detergent activation of lysosomal acid beta-glucosidase in the spleen of normal and type 1 Gaucher patients is not accompanied by change in aggregation state.
    Maret A; Potier M; Salvayre R; Troly M; Beauregard G; Douste-Blazy L
    Biochim Biophys Acta; 1989 Jul; 996(3):254-6. PubMed ID: 2502183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Glucosidase activities in the Norrbotten type of juvenile Gaucher's disease.
    Hultberg B
    Acta Neurol Scand; 1978 Aug; 58(2):89-94. PubMed ID: 30251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.